Vulnerable Populations: who are they?
This is the fourth in a series of articles about medical ethics. Our previous posts in this series included the basics of medical ethics, the difference between utilitarianism and deontology, and the Belmont Report.
Today we will review vulnerable populations. The idea of vulnerable populations falls under the ethical construct of respect for persons. Remember that this principle is about autonomy, where
Good Clinical Practice glossary series
Welcome back to the Hart GCP knowledge series. We have been reviewing essential documents that are typically generated before the clinical phase of the trial begins. We have looked specifically at the Investigator brochure, clinical protocol/protocol amendments, informed consent tracking, and the use of advertisements. Today we will be reviewing financial documents and insurance required prior to beginning a clinical trial.
This installment of Hart Health Hints celebrates a year of this blog series that aims to inform our viewers about some important health tips. We especially love finding out about events in our communities that help bring awareness to health problems that our friends, our families, or ourselves may have.
In our industry, we are experts in technical details of the disease processes and cutting-edge treatment
August 13-19, 2017 is National Health Center Week
Did you know that community Health Centers provide care for over 25 million Americans at more than 9,000 locations across the country?
This August, the National Association of Community Health Centers, is sponsoring the National Health Center Week, with a theme of “Celebrating America’s Health Centers: The Key to Healthier Communities.”
Health centers are community-based and community-directed organizations that provide
This, HCC’s 50th blog post, is a message of celebration. Since we are halfway through 2017, I’d like to share with you some things I am exceptionally happy about and graciously thankful for.
One of our goals for this year was to continue to provide high-quality service in the areas in which we excel. As Risk-Based Monitoring (RBM) continues to grow and become accepted as an
Hart Healthy Challenge Grand Finale!
We have successfully completed our 2017 Hart Healthy Month and our Hartians all did a phenomenal job of becoming more aware of their day-to-day activities and eating habits.
As was expected, some people were able to do more than others, but the point is to start somewhere, even if that somewhere is contemplation and awareness. The funny thing is… that advice applies
March is National Kidney Month
Did you know that 1 in 3 US adults is at risk for kidney disease and that it can go undetected for a very long time? Did you also know that chronic kidney disease or CKD affects 26 million American adults? Main risks for CKD are diabetes and high blood pressure, which are responsible in approximately two-thirds of all cases.
Hart Healthy Challenge continued: happy eating
We are just about three-quarters of the way through our Hart Healthy Month and wanted to share some of our activities with you!
Along with our physical activity goals, our team is engaging in nutritional goals as well. Here is a sampling of those goals:
Reducing food intake by 25%
Eating more veggies
Eating less junk food
Reducing sugars and caffeine
Essential documents Deep Dive: Advertisements
Hart’s Good Clinical Practice glossary series
Welcome back to the Hart GCP knowledge series. We have been reviewing essential documents that are typically generated before the clinical phase of the trial begins. We have looked specifically at the Investigator brochure and clinical protocol/protocol amendments and informed consent tracking in this portion of our glossary series.
The Good Clinical Practice (GCP) guideline states that
Essential documents Deep Dive: informed consent tracking Hart’s Good Clinical Practice glossary series
Welcome back to the Hart GCP knowledge series. We have been reviewing essential documents that are typically generated before the clinical phase of the trial begins. We have looked specifically at the Investigator brochure and clinical protocol/protocol amendments in this portion of our glossary series.
Image courtesy of fda.com
Informed consent is a broad subject and